# Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting

> **NCT01638299** · PHASE1 · COMPLETED · sponsor: **Animas Corporation** · enrollment: 20 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Hypo-Hyper Minimizer (HHM) System

## Key facts

- **NCT ID:** NCT01638299
- **Lead sponsor:** Animas Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638299, "Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01638299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*